Europe — EMA
Pangrol (Pancreas Powder)
GNH USA supplies Pangrol (Pancreas Powder), a drug for unspecified indications. Request a quote for global supply to hospitals, pharmacies and clinics.
Request sourcing
What is Pancreas Powder?
Pancreas Powder, the active ingredient in Pangrol, is a drug presented as an oral preparation for systemic use. It is not classified within a defined therapeutic class, and no specific clinical indications have been established in major regulatory databases. The substance is derived from pancreatic tissue extracts and is marketed in the European Union.
GNH USA supplies Pangrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing quality‑assured products that meet EU regulatory standards.
What is Pancreas Powder used for?
Pangrol (Pancreas Powder) currently has no established therapeutic indications in recognized medical guidelines.
What are the side effects of Pancreas Powder?
Adverse reactions reported for Pangrol (Pancreas Powder) are limited, and the safety profile is not fully characterized.
Common Side Effects: - Gastrointestinal discomfort: mild nausea, abdominal cramping or flatulence reported in some users. - Allergic skin reaction: localized rash or itching. - Diarrhea: loose stools observed. - Constipation: occasional difficulty passing stool.
Serious or Rare Side Effects: - Anaphylaxis: rare severe allergic response requiring immediate medical attention. - Pancreatitis exacerbation: potential worsening of underlying pancreatic inflammation. - Severe hypoglycemia: rare episodes in susceptible individuals. - Hepatic enzyme elevation: occasional increase in liver function tests.
What precautions apply to Pancreas Powder?
When considering Pangrol (Pancreas Powder), several precautionary measures should be observed to minimize risk.
- Indication verification: confirm that use aligns with any approved or investigational protocol. - Allergy assessment: screen for known hypersensitivity to pancreatic extracts or related proteins. - Renal function monitoring: evaluate kidney status as oral enzyme preparations may affect renal clearance. - Concomitant enzyme therapy: avoid simultaneous use of other pancreatic enzyme products without medical guidance. - Pregnancy and lactation: defer use unless benefits outweigh potential risks, as safety data are lacking. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture and direct sunlight.
What does Pancreas Powder interact with?
Potential drug interactions with Pangrol (Pancreas Powder) have not been extensively studied; however, theoretical considerations suggest caution with certain agents.
Major Interactions (Avoid): - Antacids: may alter gastric pH and affect enzyme activity. - Proton pump inhibitors: reduced efficacy of oral enzymes due to decreased acidity. - High‑dose oral protease inhibitors: possible competitive inhibition of pancreatic enzymes.
Moderate Interactions (Monitor Closely): - Oral anticoagulants: monitor INR as enzyme preparations can affect vitamin K metabolism. - Diabetic medications: observe blood glucose as digestive enzyme changes may influence carbohydrate absorption. - Antibiotics with GI side effects: increased risk of combined gastrointestinal discomfort.



